With a therapy that could improve and save the lives of millions, Innovation Gateway is backing a VCU School of Pharmacy researcher with a novel and promising treatment for sickle cell disease. Clinical trials for the treatment, licensed to VCU startup IllExcor Therapeutics, are tentatively slated to start in 2022 in England. Read more.